Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Use of Accelerometers to Measure Real-Life Physical Activity in Ambulatory Individuals with Multiple Sclerosis: A Pilot Study.
Socioeconomic Factors in Childhood and the Risk of Multiple Sclerosis.
Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysis.
Acute disseminated encephalomyelitis after treatment of Plasmodium vivax malaria.
Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.
Auraptene induces oligodendrocyte lineage precursor cells in a cuprizone-induced animal model of demyelination.
Activation of the adenosine A2A receptor exacerbates experimental autoimmune neuritis in Lewis rats in association with enhanced humoral immunity.
Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study.
Author response.
The P66Shc/Mitochondrial Permeability Transition Pore Pathway Determines Neurodegeneration.
Visualization of acute focal lesions in rats with experimental autoimmune encephalomyelitis by magnetic nanoparticles, comparing different MRI sequences including phase imaging.
Systematic review of occupational therapy-related interventions for people with multiple sclerosis: part 1. Activity and participation.
Structural correlates of subjective and objective memory performance in multiple sclerosis.
The gateway theory: How regional neural activation creates a gateway for immune cells via an inflammation amplifier.
Disease Activity Free Status: A New End Point for a New Era in Multiple Sclerosis Clinical Research?
Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions.
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine.
Neurophysiological Evidence of Compensatory Brain Mechanisms in Early-Stage Multiple Sclerosis.
Abstracts.
Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease.
The influence of glutamatergic receptor antagonists on biochemical and ultrastructural changes in myelin membranes of rats subjected to experimental autoimmune encephalomyelitis.
Cambridge Healthtech Institute's Third Annual Anti-inflammatories: small Molecules Meeting, April 17(th) - 18(th) 2012, San Diego, USA.
Systematic Review and meta-analysis of the Efficacy of sphingosine-1-phosphate (S1P) receptor agonist FTY720 (fingolimod) in Animal Models of Stroke.
[The effect of genetic factors on the phenotypic expression of multiple sclerosis.]

Pages